982 related articles for article (PubMed ID: 25321323)
21. Sublobar resection versus definitive radiation in patients with stage IA non-small cell lung cancer.
Fernandez FG; Crabtree TD; Liu J; Meyers BF
Ann Thorac Surg; 2012 Aug; 94(2):354-60; discussion 360-1. PubMed ID: 22429673
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
23. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung.
Lutfi W; Schuchert MJ; Dhupar R; Sarkaria I; Christie NA; Yang CJ; Deng JZ; Luketich JD; Okusanya OT
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):517-524. PubMed ID: 31177277
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study.
Yang H; Xiao X; Mei T; Zhou P
Aging Clin Exp Res; 2022 Aug; 34(8):1925-1934. PubMed ID: 35347580
[TBL] [Abstract][Full Text] [Related]
25. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
[TBL] [Abstract][Full Text] [Related]
26. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.
Bryant AK; Mundt RC; Sandhu AP; Urbanic JJ; Sharabi AB; Gupta S; Daly ME; Murphy JD
Ann Thorac Surg; 2018 Feb; 105(2):425-431. PubMed ID: 29198624
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
[TBL] [Abstract][Full Text] [Related]
30. Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer.
Tsutani Y; Tsubokawa N; Ito M; Misumi K; Hanaki H; Miyata Y; Okada M
Eur J Cardiothorac Surg; 2018 Feb; 53(2):366-371. PubMed ID: 28958068
[TBL] [Abstract][Full Text] [Related]
31. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
32. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.
Kates M; Swanson S; Wisnivesky JP
Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736
[TBL] [Abstract][Full Text] [Related]
33. Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
de Ruiter JC; van Diessen JNA; Smit EF; van der Noort V; Damhuis RAM; Hartemink KJ;
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35348664
[TBL] [Abstract][Full Text] [Related]
34. Sublobar resection is comparable to lobectomy for screen-detected lung cancer.
Kamel MK; Lee B; Harrison SW; Port JL; Altorki NK; Stiles BM
J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1907-1915. PubMed ID: 34281703
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
Chen H; Laba JM; Boldt RG; Goodman CD; Palma DA; Senan S; Louie AV
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):186-194. PubMed ID: 29619964
[TBL] [Abstract][Full Text] [Related]
36. Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers--a Surveillance Epidemiology End Results database analysis.
Yendamuri S; Sharma R; Demmy M; Groman A; Hennon M; Dexter E; Nwogu C; Miller A; Demmy T
J Surg Res; 2013 Jul; 183(1):27-32. PubMed ID: 23260233
[TBL] [Abstract][Full Text] [Related]
37. Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC.
Husain ZA; Kim AW; Yu JB; Decker RH; Corso CD
Clin Lung Cancer; 2015 Nov; 16(6):e183-7. PubMed ID: 25979646
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
Lin Q; Sun X; Zhou N; Wang Z; Xu Y; Wang Y
BMC Pulm Med; 2019 May; 19(1):98. PubMed ID: 31118007
[TBL] [Abstract][Full Text] [Related]
39. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
